Directors Dealings
Director dealings are proprietary transactions by executives, which are reportable under Art. 19 MAR. The publication of these transactions is an important contribution to the prevention of insider dealing and market manipulation. In addition, knowledge of such transactions is of great importance to the market, as these transactions provide indications of management's assessment of the company's future business prospects. The information presented here relates to companies that are under the supervision of BaFin.
RWE Aktiengesellschaft: A reportable insider transaction was published on 7th October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 7th October 2024,
The Insider Transaction was made by Appel, Frank 
. The transaction toke place on 4th October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 125.440,00 EUR, based on an average price of 31,36 EUR. The nature of the Investment was Buy.
RWE Aktiengesellschaft: A reportable insider transaction was published on 2nd October 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 2nd October 2024,
The Insider Transaction was made by Appel, Frank . The transaction toke place on 1st October 2024. The order was executed at the trading place XETRA. . The aggregated volume was 130.788,00 EUR, based on an average price of 32,70 EUR. The nature of the Investment was Buy.
Private Assets SE & Co. KGaA: A reportable insider transaction was published on 2nd September 2024. The reporting obligation was triggered by a person related to Other executive.
Transaction reporting date: 2nd September 2024,
The Insider Transaction was made by Arendt, Frank . The transaction toke place on 28th August 2024. The order was executed at the trading place Börse Berlin AG. . The aggregated volume was 28.710,00 EUR, based on an average price of 8,70 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 28th August 2024. The order was executed at the trading place Xetra. . The aggregated volume was 4.985,50 EUR, based on an average price of 2,49 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 29th August 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 29th August 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 28th August 2024. The order was executed at the trading place Berlin Tradegate. . The aggregated volume was 4.968,08 EUR, based on an average price of 2,48 EUR. The nature of the Investment was Buy.
Berliner Effektengesellschaft AG: A reportable insider transaction was published on 20th August 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 20th August 2024,
The Insider Transaction was made by Fricke, Frank-Uwe . The transaction toke place on 19th August 2024. The order was executed at the trading place Tradegate Exchange. . The aggregated volume was 29.100,00 EUR, based on an average price of 64,67 EUR. The nature of the Investment was Buy.
Tradegate AG: A reportable insider transaction was published on 20th August 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 20th August 2024,
The Insider Transaction was made by Fricke, Frank-Uwe . The transaction toke place on 19th August 2024. The order was executed at the trading place Tradegate Exchange. . The aggregated volume was 42.000,00 EUR, based on an average price of 93,33 EUR. The nature of the Investment was Buy.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 10th June 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 10th June 2024,
The Insider Transaction was made by Köhler, Elena . The transaction toke place on 7th June 2024. The order was executed at the trading place Xetra. . The aggregated volume was 49.938,00 EUR, based on an average price of 118,90 EUR. The nature of the Investment was Buy.
DEUTSCHE BANK AKTIENGESELLSCHAFT: A reportable insider transaction was published on 31st July 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 31st July 2024,
The Insider Transaction was made by Witter, Frank . The transaction toke place on 29th July 2024. The order was executed at the trading place Xetra. . The aggregated volume was 26.901,85 EUR, based on an average price of 14,52 EUR. The nature of the Investment was not specified.
Redcare Pharmacy N.V.: A reportable insider transaction was published on 10th June 2024. The reporting obligation was triggered by a person related to Closely associated.
Transaction reporting date: 10th June 2024,
The Insider Transaction was made by Köhler, Elena . The transaction toke place on 7th June 2024. The order was executed at the trading place Xetra. . The aggregated volume was 49.938,00 EUR, based on an average price of 118,90 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 3rd June 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd June 2024,
The Insider Transaction was made by Weber, Frank . The transaction toke place on 31st May 2024. . The aggregated volume was 851.583,31 EUR, based on an average price of 92,74 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 3rd June 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 3rd June 2024,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 31st May 2024. . The aggregated volume was 464.929,99 EUR, based on an average price of 92,74 EUR. The nature of the Investment was Buy.
Bayerische Motoren Werke Aktiengesellschaft: A reportable insider transaction was published on 27th May 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 27th May 2024,
The Insider Transaction was made by Mertl, Walter . The transaction toke place on 27th May 2024. . The aggregated volume was 26.746,70 EUR, based on an average price of 93,19 EUR. The nature of the Investment was Buy.
Medigene AG: A reportable insider transaction was published on 15th May 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 15th May 2024,
The Insider Transaction was made by Mathias, Dr. Frank . The transaction toke place on 13th May 2024. . The aggregated volume was 6.963,60 EUR, based on an average price of 1,20 EUR. The nature of the Investment was Buy.
Heidelberg Pharma AG: A reportable insider transaction was published on 17th April 2024. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th April 2024,
The Insider Transaction was made by Miller, Walter . The transaction toke place on 15th April 2024. The order was executed at the trading place Berlin Tradegate. . The aggregated volume was 6.050,00 EUR, based on an average price of 3,02 EUR. The nature of the Investment was Buy.
Fresenius SE & Co. KGaA: A reportable insider transaction was published on 13th March 2024. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 13th March 2024,
The Insider Transaction was made by Appel, Dr. Frank . The transaction toke place on 12th March 2024. The order was executed at the trading place XETRA. . The aggregated volume was 50.960,00 EUR, based on an average price of 25,48 EUR. The nature of the Investment was Buy.
Knorr-Bremse Aktiengesellschaft: A reportable insider transaction was published on 10th November 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 10th November 2023,
The Insider Transaction was made by Weber, Frank Markus . The transaction toke place on 9th November 2023. The order was executed at the trading place XETRA. . The aggregated volume was 100.616,46 EUR, based on an average price of 55,25 EUR. The nature of the Investment was Buy.
SynBiotic SE: A reportable insider transaction was published on 23rd October 2023. The reporting obligation was triggered by a person related to Supervisory Board.
Transaction reporting date: 23rd October 2023,
The Insider Transaction was made by Otto, Frank . The transaction toke place on 17th October 2023. . The aggregated volume was 354.474,00 EUR, based on an average price of 3,60 EUR. The nature of the Investment was not specified.
Deutsche Effecten- und Wechsel-Beteiligungsgesellschaft AG: A reportable insider transaction was published on 28th August 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 28th August 2023,
The Insider Transaction was made by Köhler, Bertram . The transaction toke place on 25th August 2023. . The aggregated volume was 152.880,00 EUR, based on an average price of 0,78 EUR. The nature of the Investment was Buy.
SAF-HOLLAND SE: A reportable insider transaction was published on 17th August 2023. The reporting obligation was triggered by a person related to Management Board.
Transaction reporting date: 17th August 2023,
The Insider Transaction was made by Lorenz-Dietz, Frank . The transaction toke place on 15th August 2023. The order was executed at the trading place Xetra. . The aggregated volume was 5.750,00 EUR, based on an average price of 11,50 EUR. The nature of the Investment was Buy.
Disclaimer:
The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster.
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.
If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.